# Medtronic Terminate AF Study

Study · id `cardio:ct-nct03546374` · Cardiovascular Atlas · release `a25293eeae6350fb` (public)

> General information from published sources, not medical advice, and not reviewed by clinicians. Check the cited source before relying on anything here. Sponsors do not influence what this atlas says.

The atlas's own text and curation may be reused under Creative Commons Attribution-NonCommercial 4.0 International (CC BY-NC 4.0, https://creativecommons.org/licenses/by-nc/4.0/): credit the atlas, and do not use it commercially without a licence from the owner. See the atlas About page. Text quoted from a source stays under that source's own terms, given as the source's reuse\_basis. The atlas's reuse terms do not cover it. The downloads list each quotation with its source in third\_party\_quotations.

**Registry record.** Assembled by a program from [ClinicalTrials.gov record NCT03546374](<https://clinicaltrials.gov/study/NCT03546374>), retrieved 26 October 2026. No person wrote or checked this page.

Also called: NCT03546374

Browse, organ or system: Heart  
Browse, condition area: Stroke; Heart rhythm problems  

## In plain language

A trial with no phase registered on ClinicalTrials.gov. The registry status is recruiting. It plans to enroll 160 participants.

## Technical summary

Registry record NCT03546374. Allocation not applicable; no masking; primary purpose treatment. Start 2018-11-15 (actual); primary completion 2024-10-01 (actual). Results not posted.

## Key facts

- Design: Interventional study; allocation not applicable; no masking; primary purpose treatment
- Phase: Not applicable
- Enrolled: 160 participants (planned count; ClinicalTrials.gov record NCT03546374, source copy `cardio:ctgov-nct03546374-2026-05-14`, retrieved 2026-10-26)
- Started: 2018-11-15 (actual) (ClinicalTrials.gov record NCT03546374, source copy `cardio:ctgov-nct03546374-2026-05-14`, retrieved 2026-10-26)
- Primary completion: 2024-10-01 (actual) (ClinicalTrials.gov record NCT03546374, source copy `cardio:ctgov-nct03546374-2026-05-14`, retrieved 2026-10-26)
- Completion: 2026-12 (anticipated) (ClinicalTrials.gov record NCT03546374, source copy `cardio:ctgov-nct03546374-2026-05-14`, retrieved 2026-10-26)
- Countries: United States (ClinicalTrials.gov record NCT03546374, source copy `cardio:ctgov-nct03546374-2026-05-14`, retrieved 2026-10-26)
- Care setting: Not reported
- Registry status: "RECRUITING" (U.S. National Library of Medicine (ClinicalTrials.gov), source copy `cardio:ctgov-nct03546374-2026-05-14`, retrieved 2026-10-26)

## The registry's words

- Brief title: Medtronic Terminate AF Study
- Condition: Persistent Atrial Fibrillation
- Condition: Longstanding Persistent Atrial Fibrillation
- Intervention (Procedure): Surgical Ablation
- Intervention (Device): Cardioblate and Cryoflex hand held devices
- Lead sponsor: Medtronic Cardiac Surgery
- Lead sponsor class: INDUSTRY

## Connected pages

- Registry condition terms include this condition: Arrhythmia (heart rhythm problems) (`cardio:arrhythmia`)
- Registry condition terms include this condition: Atrial fibrillation (AF) (`cardio:atrial-fibrillation`)
- Registry lists this organization as the lead sponsor: Medtronic Cardiac Surgery (`cardio:org-medtronic-cardiac-surgery`)

## Provenance

Content hash: 06dfc61014efec45e95fb5ea09a54e6fa87554ffc384bce9a6f39280dbb05052
Last substantive edit: 2026-11-08
Evidence last checked: Not recorded
